84
82
Growth Score
-3 pts
Heat Score
19 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
664136
Precision Medicines is dedicated to improving the lives of cancer patients through developing novel targeted medicines.
- Jarl Ulf Jungnelius: Chief Medical Officer
Ansar Jawaid: Founder and Chief Executive Officer
About the Company
Precision Medicines is dedicated to improving the lives of cancer patients through developing novel targeted medicines.
Precision Medicines is a clinical stage biotechnology company focussed on in-licensing innovative drug candidates that are undergoing or have already completed initial clinical testing for the treatment of various forms of cancer
and then seek to further develop these drug candidates for commercial use.
The development programs are focused on cancer sub types using a precision or personalized medicine approach, whereby therapies are co-developed with companion biomarkers to target the specific drivers of cancers.
